✦ LIBER ✦

‘Fit-for-purpose’ method validation of cerebrospinal fluid Alzheimer's biomarkers (Aβ38, Aβ40, Aβ42, ptau181 and total tau)

✍ Scribed by Lorella Di Donato

Book ID: 118468116
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 67 KB
Volume: 8
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2012.05.2002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of cerebrospinal fluid tau,

Combination of cerebrospinal fluid tau, Aβ40 and Aβ42 analyses in the diagnosis of Alzheimer's disease

✍ Tero Tapiola; Tuula Pirttila; Pankaj D. Mehta; Irina I. Alafuzoff; Maarit Lehtov 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 197 KB

A Selected Reaction Monitoring (SRM)-Bas

A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of Aβ38, Aβ40, and Aβ42 in Cerebrospinal Fluid of Alzheimer's Disease Patients and Healthy Controls

✍ Pannee, Josef ;Portelius, Erik ;Oppermann, Madalina ;Atkins, Alan ;Hornshaw, Mar 📂 Article 📅 2013 🏛 IOS Press 🌐 English ⚖ 435 KB

Longitudinal study of cerebrospinal flui

Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan

✍ M. Kanai; E. Matsubara; K. Isoe; K. Urakami; K. Nakashima; H. Arai; H. Sasaki; K 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 919 KB

To clarify the alterations of tau, amyloid beta protein (A beta) 1-40 and A beta1-42(43) in the cerebrospinal fluid (CSF) that accompany normal aging and the progression of Alzheimer's disease (AD), CSF samples of 93 AD patients, 32 longitudinal subjects among these 93 AD patients, 33 patients with

Advances in the development of biomarker

Advances in the development of biomarkers for Alzheimer’s disease: from CSF total tau and Aβ1–42 proteins to phosphorylated tau protein

✍ Harald Hampel; Alexander Goernitz; Katharina Buerger 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB